A detailed history of Gamma Investing LLC transactions in Valneva Se stock. As of the latest transaction made, Gamma Investing LLC holds 1,857 shares of VALN stock, worth $16,805. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,857
Previous 2,117 12.28%
Holding current value
$16,805
Previous $25.8 Million 36.58%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 02, 2026

SELL
$8.72 - $11.57 $2,267 - $3,008
-260 Reduced 12.28%
1,857 $16.4 Million
Q3 2025

Oct 02, 2025

BUY
$5.72 - $12.2 $4,215 - $8,991
737 Added 53.41%
2,117 $25.8 Million
Q2 2025

Jul 14, 2025

SELL
$5.5 - $7.05 $3,855 - $4,942
-701 Reduced 33.69%
1,380 $7.83 Million
Q1 2025

Apr 14, 2025

SELL
$4.31 - $8.33 $51,215 - $98,985
-11,883 Reduced 85.1%
2,081 $14 Million
Q1 2025

Apr 07, 2025

BUY
$4.31 - $8.33 $60,184 - $116,320
13,964 New
13,964 $2.08 Million

Others Institutions Holding VALN

About Valneva SE


  • Ticker VALN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,103,504
  • Market Cap $625M
  • Description
  • Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...
More about VALN
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.